We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Incision-Free Procedure for GERD

By HospiMedica staff writers
Posted on 03 Oct 2005
The first trans-oral, incision-free endoluminal fundoplication procedure for treating severe gastroesophageal reflux disease (GERD) was recently performed by Prof. More...
Guy-Bernard Cadiere from the University of Brussels (Belgium).

"GERD is a serious disease and reflux more than three times a week or more than 20 times a year makes cancer 15 times more likely,” observed Prof. Cadiere. "About 10% of individuals with chronic GERD develop a precancerous condition, Barrett's esophagus, and 10% of these progress to cancer.”

The new procedure involves inserting a device through the mouth and into the stomach to access and reconstruct the gastroesophageal valve, thereby preventing reflux of stomach contents into the esophagus and throat. To date, seven patients have been successfully treated with the new device and procedure. Currently, there are no effective methods of curing GERD without abdominal incisions and surgical manipulation of the stomach and esophagus. The new procedure was developed by EndoGastric Solutions, Inc. (EG, Redmond, WA, USA).

Other companies have tried to develop minimally invasive endoscopic approaches to GERD but none of their products worked very well because they did not increase the competence of the gastroesophageal valve and anti-reflex barrier, according to Dr. Cadiere.

"The important thing is that we are using proven techniques and methodologies, such as the manipulations of the gastroesophageal valve as they are performed during surgery, without cutting through the abdominal wall,” added Dr. Stefan Kraemer, chief medical officer of EG Solutions.




Related Links:
EG Solutions

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.